Earnings call transcript: Elite Pharma sees 52% revenue growth in Q1 2025

6 days ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. Earnings call transcript: Elite Pharma sees 52% revenue growth in Q1 2025

Related

China issues warning to Trump over tariffs, vows countermeasures targeting key US supply chains

China issues warning to Trump over tariffs, vows countermeas...

5 minutes ago 0
Ascentage Pharma appoints Veet Misra as CFO

Ascentage Pharma appoints Veet Misra as CFO

12 minutes ago 0
Associated Capital estimates Q2 book value growth to $43.20-$43.40 per share

Associated Capital estimates Q2 book value growth to $43.20-...

21 minutes ago 0
Asia markets rise as new tariff rates hit Japan, South Korea, delays broader deadline

Asia markets rise as new tariff rates hit Japan, South Korea...

49 minutes ago 0
'He’s forging peace as we speak': Netanyahu nominates Trump for Nobel Peace Prize after Iran strikes

'He’s forging peace as we speak': Netanyahu nominates Trump ...

56 minutes ago 0
EU skips Trump tariff letter, eyes exemptions - report

EU skips Trump tariff letter, eyes exemptions - report

1 hour ago 0
Titan share down over 11% from all-time high: Should you buy dip after mixed Q1 business update?

Titan share down over 11% from all-time high: Should you buy...

1 hour ago 0
First Trade: Indices open little changed; Nifty hovers around 25,440 levels; Titan down over 4%

First Trade: Indices open little changed; Nifty hovers aroun...

1 hour ago 0
Gold vs Nifty 50 5-year Return Comparison: Where did investor get higher return on Rs 5,00,000 investment?

Gold vs Nifty 50 5-year Return Comparison: Where did investo...

1 hour ago 0
Heat Alert in Tamil Nadu, Puducherry: RMC forecasts sharp temperature spike, urges precautions

Heat Alert in Tamil Nadu, Puducherry: RMC forecasts sharp te...

1 hour ago 0
Should you buy Exide shares now? Fundamental stock picks and more

Should you buy Exide shares now? Fundamental stock picks and...

1 hour ago 0
Samsung warns Q2 profit drop of 56% due to weak AI chip demand

Samsung warns Q2 profit drop of 56% due to weak AI chip dema...

1 hour ago 0
Monthly Income From One-time Investment: How your Rs 25 lakh investment can generate Rs 4.36 lakh/month for 30 years

Monthly Income From One-time Investment: How your Rs 25 lakh...

1 hour ago 0
india stock market news today july 8 2025 nifty 50 sensex bank nifty small midcap us india trade deal anil singhvi view

india stock market news today july 8 2025 nifty 50 sensex ba...

1 hour ago 0
India-US to likely announce trade deal soon: Check how Anil Singhvi interprets it for Indian equities

India-US to likely announce trade deal soon: Check how Anil ...

2 hours ago 0
Market Strategy Today (July 8): How to trade Nifty 50, Nifty Bank today? Key levels to track & more

Market Strategy Today (July 8): How to trade Nifty 50, Nifty...

2 hours ago 0
Pharma stocks in focus: Brokerages slash ratings and price targets, Aurobindo downgraded sharply

Pharma stocks in focus: Brokerages slash ratings and price t...

2 hours ago 0
Luxfer Holdings declares $0.13 dividend

Luxfer Holdings declares $0.13 dividend

2 hours ago 1
Pre-market Update (July 8): Gift Nifty down 41 points; Indian markets may open lower amid Trump tariff shock

Pre-market Update (July 8): Gift Nifty down 41 points; India...

2 hours ago 0
A. O. Smith Corporation declares $0.34 dividend

A. O. Smith Corporation declares $0.34 dividend

2 hours ago 1

Trending

1. upmsp result
2. delhi high court
3. dte
4. rattanindia power share price
5. bse share price
6. alok industries
7. varun beverages share price
8. cuddalore train accident
9. punjab and haryana high court
10. trident share price

Popular

Home Depot is buying GMS for about $4.3 billion as retailer chases more home pros

Home Depot is buying GMS for about $4.3 billion as retailer ...

1 week ago 7
TechCrunch Mobility: The state of EV sales and Rivian secures the next $1B from VW

TechCrunch Mobility: The state of EV sales and Rivian secure...

3 days ago 6
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved